EX-5.1 15 dex51.htm OPINION OF NACCARATO & ASSOCIATES Opinion of Naccarato & Associates

 

Exhibit 5.1

 

NACCARATO & ASSOCIATES

Owen M. Naccarato, Esq.

19600 Fairchild, Suite 260

Irvine, CA 91612

Office: (949) 851-9261 Fax: (949) 851-9262


 

March 28, 2003

 

Calypte Biomedical Corporation

 

Re:    Opinion of Counsel—Registration Statement on Form S-8

 

Gentleman:

 

I have acted as counsel for Calypte Biomedical Corporation (the “Company”), in connection with the preparation and filing of the Company’s Registration statement on Form S-8 under the Securities Act of 1933, as amended, (the “Registration Statement”), relating to 44,812,000 shares of the Company’s common stock, $.001 par value, (the “common stock”), issuable pursuant to the Company’s Advisory and Consultants Agreements, (the “Plan”).

 

I have examined the Certificate of Incorporation, as amended, and the By-Laws of the company and all amendments thereto, the Registration Statement and originals, or copies certified to my satisfaction, of such records and meetings, written actions in lieu of meetings, or resolutions adopted at meetings, of the directors of the Company, and such other documents and instruments as in my judgement are necessary or appropriate to enable me to render the opinions expressed below.

 

Based on the foregoing examination, I am of the opinion that the shares of Common Stock issuable with the Plan are duly authorized and, when issued in accordance with the Plan, will be validly issued, fully paid and non-assessable.

 

Further, I consent to the filing of this opinion as an exhibit to the Registration Statement.

 

 
     
   

Very truly yours,

     
     
   

/s/    Owen  Naccarato

   
   

Owen Naccarato, Esq.

     
     

 

 

 

 

36